These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9145455)

  • 1. Effects of lactulose on nitrogen metabolism.
    Weber FL
    Scand J Gastroenterol Suppl; 1997; 222():83-7. PubMed ID: 9145455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora.
    Weber FL
    Dig Dis; 1996; 14 Suppl 1():53-63. PubMed ID: 8872452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters.
    Uribe-Esquivel M; Moran S; Poo JL; Muñoz RM
    Scand J Gastroenterol Suppl; 1997; 222():49-52. PubMed ID: 9145447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin.
    Weber FL; Banwell JG; Fresard KM; Cummings JH
    J Lab Clin Med; 1987 Sep; 110(3):259-63. PubMed ID: 3611949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.
    Weber FL; Fresard KM; Lally BR
    Gastroenterology; 1982 Feb; 82(2):213-7. PubMed ID: 7054022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of lactulose on urea metabolism and nitrogen excretion in cirrhotic patients.
    Weber FL
    Gastroenterology; 1979 Sep; 77(3):518-23. PubMed ID: 456846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion.
    Mortensen PB
    Hepatology; 1992 Dec; 16(6):1350-6. PubMed ID: 1446891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects.
    De Preter V; Vanhoutte T; Huys G; Swings J; Rutgeerts P; Verbeke K
    Aliment Pharmacol Ther; 2006 Apr; 23(7):963-74. PubMed ID: 16573799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactulose, disaccharides and colonic flora. Clinical consequences.
    Clausen MR; Mortensen PB
    Drugs; 1997 Jun; 53(6):930-42. PubMed ID: 9179525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics.
    Dasarathy S
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S50-3. PubMed ID: 15025256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of lactulose and magnesium sulfate on urea metabolism and nitrogen excretion in cirrhotic subjects.
    Weber FL; Fresard KM
    Gastroenterology; 1981 May; 80(5 pt 1):994-8. PubMed ID: 7202981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In hepatic coma, the problem comes from the colon, but will the answers come from there?
    Schafer DF
    J Lab Clin Med; 1987 Sep; 110(3):253-4. PubMed ID: 3611947
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
    Bongaerts G; Severijnen R; Timmerman H
    Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for hepatic encephalopathy.
    Schiano TD
    Pharmacotherapy; 2010 May; 30(5 Pt 2):16S-21S. PubMed ID: 20412036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
    Morgan MY
    Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine intestinal ammonia liberation. Influence of food intake, lactulose and neomycin treatment.
    van Berlo CL; van Leeuwen PA; Soeters PB
    J Hepatol; 1988 Oct; 7(2):250-7. PubMed ID: 3192927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.
    Huang E; Esrailian E; Spiegel BM
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1147-61. PubMed ID: 17894657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.